Electrical machine and use thereof
    2.
    发明申请
    Electrical machine and use thereof 有权
    电机及其用途

    公开(公告)号:US20060131974A1

    公开(公告)日:2006-06-22

    申请号:US10524388

    申请日:2003-08-13

    Abstract: The invention relates to an electrical machine of the transversal-flux type. The machine comprises a stator and a movable element. The stator has a plurality of stator elements with magnetic flux conductors and an electric winding extending in a closed winding path through each magnetic flux conductor. The movable element comprises a number of permanent-magnet members and is movable in relation to the stator along a movement path. The winding path comprises a first current-carrying section extending along the movement path. Each magnetic flux conductor forms, together with one of the permanent-magnet members, a closed magnetic flux circuit around said current-carrying section. Each permanent-magnet member comprises a primary magnet with a magnetic direction across the movement path. Adjacently located permanent-magnet members are separated from each other by an intermediate member comprising at least one secondary magnet that has a magnetic direction essentially across the magnetic direction of the primary magnet.

    Abstract translation: 本发明涉及横向磁通型电机。 机器包括定子和可移动元件。 定子具有多个具有磁通导体的定子元件和在闭合绕组通路中延伸穿过每个磁通导体的电绕组。 可移动元件包括多个永磁体构件,并且可沿着移动路径相对于定子移动。 卷绕路径包括沿移动路径延伸的第一载流部分。 每个磁通导体与一个永磁体构件一起形成围绕所述载流部分的闭合磁通电路。 每个永磁体构件包括穿过移动路径的磁方向的主磁体。 相邻的永磁体构件通过中间构件彼此分离,所述中间构件包括至少一个具有基本上横跨主磁体的磁方向的磁方向的次级磁体。

    CYTIDINE ANALOGS FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES
    6.
    发明申请
    CYTIDINE ANALOGS FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES 审中-公开
    用于治疗脑脊液综合征的CYTIDINE ANALOGS

    公开(公告)号:US20100311683A1

    公开(公告)日:2010-12-09

    申请号:US12740636

    申请日:2008-11-03

    CPC classification number: A61K31/7068

    Abstract: The present invention provides methods of treating a patient having a higher risk myelodysplastic syndrome, which comprises administering to a patient having a higher risk myelodysplastic syndrome a therapeutically effective amount of a cytidine analog. The cytidine analog includes 5-aza-2′-deoxy cytidine, 5-azacytidine, 5-aza-2′-deoxy- 2′,2′-difluorocytidine, 5-aza-2-40 -deoxy-2′-fluorocytidine, 2′-deoxy-2′,2′-difluorocytidine, cytosine 1-β-D-arabinofuranoside, 2(1H) pyrimidine riboside, 2′-cyclocytidine, arabinofuanosyl-5-azacytidine, dihydro-5-azacytidine, N4-octadecyl-cytarabine, and elaidic acid cytarabine

    Abstract translation: 本发明提供治疗具有更高风险的骨髓增生异常综合征的患者的方法,其包括对具有较高危险性骨髓增生异常综合征的患者施用治疗有效量的胞苷类似物。 胞苷类似物包括5-氮杂-2'-脱氧胞苷,5-氮杂胞苷,5-氮杂-2'-脱氧-2',2'-二氟胞苷,5-氮杂-2-40-脱氧-2'-氟胞苷, 2'-脱氧-2',2'-二氟胞苷,胞嘧啶1-糖基-D-阿拉伯呋喃糖苷,2(1H)嘧啶核苷,2'-环胞苷,阿拉伯呋喃糖基-5-氮杂胞苷,二氢-5-氮杂胞苷,N4-十八烷基 - 海藻酸和雷阿酸阿糖胞苷

Patent Agency Ranking